US Stock MarketDetailed Quotes

CTSO Cytosorbents

Watchlist
  • 1.080
  • +0.040+3.85%
Close Aug 23 16:00 ET
  • 1.080
  • 0.0000.00%
Post 20:02 ET
58.78MMarket Cap-2076P/E (TTM)

Cytosorbents Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Cytosorbents Q2 2024 Earnings Date

Currency：USDAug 13, 2024

Estimate
(YoY)		 Actual
(YoY)		 Vs Estimate
(% Chg)
Revenue
9.68M
9.89M
+212.14K
Beat Est.
+2.78%
+5.03%
+2.19%
EPS
-0.10
-0.08
+0.02
Beat Est.
+30.38%
+42.86%
+17.86%
Analyst Rating
Buy

Aug 14, 2024

Cytosorbents Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 4 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2024/Q4-- / 9.902M--
--2024/Q3-- / 9.905M--
Aug 13, 20242024/Q29.895M / 9.683M--
May 9, 20242024/Q19.787M / 9.785M--
Mar 14, 20242023/Q48.668M / 9.840M--
DatePeriodRevenue/EstimateEarnings Call
--2024/Q4-- / 9.902M--
--2024/Q3-- / 9.905M--
Aug 13, 20242024/Q29.895M / 9.683M--
May 9, 20242024/Q19.787M / 9.785M--
Mar 14, 20242023/Q48.668M / 9.840M--

Unlock Free Earnings Estimates

Cytosorbents Earnings Reports

  • Cytosorbents | 10-Q: Q2 2024 Earnings Report

    Aug 13 16:10 ET

  • Cytosorbents | 10-Q: Q1 2024 Earnings Report

    May 9 17:02 ET

  • Cytosorbents | 10-K: FY2023 Annual Report

    Mar 15 13:21 ET

  • Cytosorbents | 10-Q: Q3 2023 Earnings Report

    Nov 9, 2023 16:10 ET

    • Read more

    Analysis

    Analyst Rating

    Updated: Aug 14, 2024

    Buy

    • Buy

      50.00%

    • Hold

      50.00%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    US
    Overall
    Symbol
    Latest Price
    % Chg